1
|
Marin GH, Giangreco L, Dorati C, Mordujovich P, Boni S, Mantilla-Ponte H, Alfonso Arvez MJ, López Peña M, Aldunate González MF, Ching Fung SM, Barcelona L, Campaña L, Vaquero Orellana A, Orjuela Rodríguez T, Ginés Cantero L, Villar RA, Sandoval Fuentes N, Melero E, Marin-Piva H, Soler G, Gabriel F, Pineda Velandia L, Ojeda Florentín C, Risso Patron S, Ortiz Rivas M, Mendoza Benítez C, Mellado R, Ivanovska V, Muller A, Rojas R, Castro JL. Antimicrobial Consumption in Latin American Countries: First Steps of a Long Road Ahead. J Prim Care Community Health 2022; 13:21501319221082346. [PMID: 35438037 PMCID: PMC9021473 DOI: 10.1177/21501319221082346] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Abstract
Background: Irrational antimicrobial consumption (AMC) became one of the main global health problems in recent decades. Objective: In order to understand AMC in Latin-American Region, we performed the present research in 6 countries. Methods: Antimicrobial consumption (J01, A07A, P01AB groups) was registered in Argentina, Chile, Colombia, Costa Rica, Paraguay, and Peru. Source of information, AMC type, DDD (Defined Daily Doses), DID (DDD/1000 inhabitants/day), population were variables explored. Data was analyzed using the Global Antimicrobial Resistance and Use Surveillance System (GLASS) tool. Results: Source of information included data from global, public, and private sectors. Total AMC was highly variable (range 1.91-36.26 DID). Penicillin was the most consumed group in all countries except in Paraguay, while macrolides and lincosamides were ranked second. In terms of type of AMC according to the WHO-AWaRe classification, it was found that for certain groups like “Reserve,” there are similarities among all countries. Conclusion and Relevance: This paper shows the progress that 6 Latin-American countries made toward AMC surveillance. The study provides a standardized approach for building a national surveillance system for AMC data analysis. These steps will contribute to the inclusion of Latin-America among the regions of the world that have periodic, regular, and quality data of AMC.
Collapse
Affiliation(s)
- Gustavo H Marin
- CUFAR-University Centre of Pharmacology, UNLP; WHO-PAHO Col., La Plata, Argentina
| | - Lucia Giangreco
- CUFAR-University Centre of Pharmacology, UNLP; WHO-PAHO Col., La Plata, Argentina
| | - Cristian Dorati
- CUFAR-University Centre of Pharmacology, UNLP; WHO-PAHO Col., La Plata, Argentina
| | - Perla Mordujovich
- CUFAR-University Centre of Pharmacology, UNLP; WHO-PAHO Col., La Plata, Argentina
| | - Silvia Boni
- ANMAT & Ministry of Health, Buenos Aires, Argentina
| | | | - Ma José Alfonso Arvez
- National Pharmacovigilance Dep-Ministry of Health, Asuncion, Gran Asunción, Paraguay
| | | | | | | | | | | | | | | | - Larissa Ginés Cantero
- National Pharmacovigilance Dep-Ministry of Health, Asuncion, Gran Asunción, Paraguay
| | - Rosa A Villar
- Pan-American Health Organization (PAHO), Washington, DC, USA
| | | | | | | | - Gisela Soler
- ANMAT & Ministry of Health, Buenos Aires, Argentina
| | | | | | | | | | - Mariela Ortiz Rivas
- National Pharmacovigilance Dep-Ministry of Health, Asuncion, Gran Asunción, Paraguay
| | | | | | | | - Arno Muller
- World Health Organization, Geneva, Switzerland
| | - Robin Rojas
- Pan-American Health Organization (PAHO), Washington, DC, USA
| | | |
Collapse
|